低细菌代谢是心室辅助装置导线感染葡萄球菌生物膜耐药的核心机制及潜在治疗靶点
本研究利用模拟皮下导线感染的隧道生物膜模型,评估七种一线抗生素对两种葡萄球菌参考菌株生物膜的活性。结果显示胞外聚合物基质不能决定性解释耐药,高密度生长和代谢抑制是关键,代谢抑制与耐药呈强负相关,增强ATP产生部分恢复敏感性,局部应用庆大霉素而非万古霉素成功杀灭生物膜。
要点
- 葡萄球菌生物膜耐药核心在于细菌代谢抑制,而非胞外基质屏障。
- 增强生物膜细胞ATP产生可部分恢复对抗生素的敏感性。
- 局部应用弱代谢依赖的庆大霉素可成功杀灭模拟导线隧道内生物膜。
核心结论
- 细菌代谢抑制是葡萄球菌生物膜耐药的核心机制,并可作为生物膜相关导线感染的有效治疗靶点。
研究设计与样本
- 采用模拟皮下导线感染的隧道生物膜模型,用两种葡萄球菌实验室参考菌株形成临床相关生物膜,测试七种一线抗生素。
主要发现
- 胞外聚合物基质不能决定性解释导线感染中葡萄球菌生物膜耐药。
- 高密度生长和细菌代谢抑制对生物膜耐药至关重要。
- 不同生物膜发育阶段的细菌代谢状态与耐药呈强负相关。
- 隧道生物膜细胞群体分析识别出低代谢活性亚群。
- 增强生物膜细胞ATP产生部分恢复了抗生素敏感性。
关键数值与推荐
- 局部应用弱代谢依赖的庆大霉素成功杀灭模拟导线隧道中的葡萄球菌生物膜,而强代谢依赖的万古霉素未成功。
临床怎么用
- 针对生物膜相关导线感染,可考虑选择弱代谢依赖的抗生素(如庆大霉素)局部应用,而非强代谢依赖的万古霉素。
- 增强细菌代谢或ATP产生的策略可能作为辅助手段提高生物膜对抗生素的敏感性。
局限性
- 研究使用两种葡萄球菌实验室参考菌株和体外隧道模型,结果需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Ventricular assist device driveline infections are difficult-to-treat diseases due to high antimicrobial resistance (AMR) of microbial biofilms. Multiple mechanisms of biofilm AMR have been proposed based on simplified in vitro models and demonstrated limited clinical implications. This study aimed to re-evaluate mechanisms contributing to staphylococcal biofilm AMR encountered in driveline infections and identify translatable therapeutic targets. METHODS: A tunnel-based biofilm assay mimicking subcutaneous driveline infections was utilized to grow clinically relevant biofilms. Seven first-line antibiotics were investigated against biofilms formed by two staphylococcal laboratory reference strains. The importance of various biofilm AMR mechanisms was evaluated, including the barrier effect of the biofilm extracellular polymeric substance (EPS) matrix, high-cell-density growth, the presence of persister cells and repressed bacterial metabolism. RESULTS: The presence of the EPS matrix couldn't decisively explain staphylococcal biofilm AMR in driveline infections. High-density growth and repressed bacterial metabolism appeared to be vital for biofilm AMR. Parallel comparisons of bacterial metabolic states and AMR at different biofilm developmental stages suggested a strong and negative correlation. Population profiling of tunnel-based biofilm cells identified subpopulations with low metabolic activity. Enhancing ATP production of biofilm cells partially restored their susceptibility to antibiotics. Local application of the weakly metabolism-dependent antibiotic gentamicin, but not the strongly metabolism-dependent vancomycin successfully killed staphylococcal biofilms in the simulated driveline tunnel, further underscoring the central role of bacterial metabolic repression in biofilm AMR. CONCLUSIONS: This study identified repressed bacterial metabolism as a central mechanism underpinning biofilm AMR and provided an effective therapeutic target for biofilm-associated driveline infections.
引用
- Sun Y, McGiffin D, Ye L, et al. Low bacterial metabolism as a central mechanism of antimicrobial resistance and potential therapeutic target of staphylococcal biofilms in ventricular assist device driveline infections. J Antimicrob Chemother. 2025. PMID: 40856264. doi:10.1093/jac/dkaf316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。